Efficient and Persistent Splice Switching by Systemically Delivered LNA Oligonucleotides in Mice
Open Access
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 14 (4) , 471-475
- https://doi.org/10.1016/j.ymthe.2006.05.017
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Monoclonal antibodies and fusion proteins in medicineJournal of Allergy and Clinical Immunology, 2005
- Regulation of Apoptosis by Alternative Pre-mRNA SplicingMolecular Cell, 2005
- Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndromeNature Medicine, 2005
- Alterations of pre‐mRNA splicing in cancerGenes, Chromosomes and Cancer, 2005
- PegaptanibDrugs, 2005
- Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal musclesProceedings of the National Academy of Sciences, 2004
- Modification of Alternative Splicing by Antisense TherapeuticsOligonucleotides, 2004
- Therapeutic potential of antisense oligonucleotides as modulators of alternative splicingJournal of Clinical Investigation, 2003
- Systemically delivered antisense oligomers upregulate gene expression in mouse tissuesNature Biotechnology, 2002
- Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other DiseasesCurrent Cancer Drug Targets, 2001